Aniara | Shaping the Future with Innovative Solutions

Learning Center

Hemostasis Happenings

Saturday, December 3, 2011


Working Group of Thrombosis and Hemostasis (in collaboration with the cardiology departments at South Valley Universities)

When:  January 12 to 14, 2012
Where: Harmony Makadi Bay
Hurghada, Eqypt

Main Topics:

  • Recent ESC guidelines.
  • What is new in antiplatelets.
  • New frontiers in hypertension.
  • Antithrombotics in 2012.
  • Acute Coronary Syndromes.

For information regarding the scientific program; please contact:
Dr. Ashraf Badawi , Coordinator of the Meeting
Cellular: +201222425779
Fax: +20226929333

For Information regarding flight, transportation, accommodation & registration please contact:
EgyCongress for International Conferences & Affairs
Cellular: + 201119422298
Fax: +20233381309

Emergency Medicine 2012

When:  January 12 and 13, 2012
Where: Hallam Conference Centre
London, England
Telephone: 01722 716 007
Email: : Emergency Medicine 2012. 12/01/2012 - 13/01/2012Conferences

Description: Emergency Medicine 2012 brings together leading experts in the fields of emergency and acute medicine, prehospital care and trauma to discuss the central issues and current challenges facing the assessment and treatment of emergency patients.
Contact: MA Healthcare Events
Telephone: 020 7501 6762 Fax:020 7733 8174

Arab Health

When: January 23 to 26, 2012
Where:Dubai, UAE

Haematology - 26th January

Moderator: Dr. Imran Mirza, Section Head, Molecular Diagnostics Laboratory, Pathology and Laboratory Medicine Institute, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Session 1 - Haemoglobinopathy/Thalassaemia

10:00: Some novel aspects of Consanguineous Marriage and their relation to common Haemoglobinopathies
Dr. Srdjan Denic,
Associate Professor, Department of Internal Medicine, UAE University, Al Ain, UAE

10:40: Clinical Management of Haemoglobinopathy/Thalassaemia
Dr. Khawla Belhowl,
Director of DHA Thalassaemia Center, Senior Officer, Dubai Health Authority, Dubai, UAE

11:10:  The Application of high resolution melting PCR to detect beta-thalassaemia mutations
Andrew Turner,
Laboratory Director, Sheikh Khalifa Medical City, Abu Dhabi, UAE

11:40: Coffee Break 

Session 2 - Haemostasis/Thromophilia

12:00: Current Management of Haemophilia
Dr. Azzam Al Zoebie,
Head of Paediatric Haematology, Sheikh Khalifa Medical City, Abu Dhabi, UAE

12:30: Current Management of ITP
Dr. Nameer Al Saadawi,
Consultant Haematologist and Head of Clinical Haematology, Sheikh Khalifa Medical City, Abu Dhabi, UAE

13:00: Thrombophilia Genotyping in the UAE
Dr. Talal Mahdi,
Specialist Haematopathologist, Head of Laboratory Department, Khorfakkan Hospital, MOH, Khorfakkan, UAE

13:30: Lunch Break

Session 3 - Leukaemia/Lymphoma

Moderator: Dr.David Spence, Consultant Clinical Haematology, Medical Institute, Sheikh Khalifa Medical Institute, Abu Dhabi, UAE

15:00: Acute Myeloid Leukaemia Diganosis in the light of WHO revisions and its correlation with the risk adaptive management
Dr. Rania Medhat Seliem, C
onsultant Haematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai, UAE

Download Case Study

15:30: Diagnosis and Classification of Lymphoma
Dr. Lois Richard,
Consultant Laboratory Pathologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE

16:00: Clinical Management Lymphoma/Myeloma
Dr. Arif Alam, Tawam, Al Ain, UAE

16:30:  Discussion (Q&A)

16:40: Closing of Haematology Track



It is our great pleasure and privilege to invite you to participate in the ALPIC 2012 (Advanced Learning on Platelets & Thrombosis International Course), the second Hellenic scientific event on Platelets and Thrombosis, held in Metsovo, Greece, January 27-29, 2012, at Diaselo Conference Center. ALPIC 2012 will be organized by the University of Ioannina, under the auspices of the Hellenic Society of Cardiology and the Mediterranean League Against Thromboembolic Diseases. This scientific event has an educational character and the programme is structured aiming to serve as a knowledge transfer forum for scientists in the various aspects of the research on Platelets and Thrombosis ranging from the basic science to the clinical practice.

ALPIC 2012 will highlight the rapid development and ongoing evolution in various topics of Platelet research including Platelet biology, Platelet function testing, the Platelet involvement in inflammation, atherosclerosis and artery wall regeneration. The important role of Platelets in the thrombotic complications of plaque rupture as well as in stent thrombosis will be also discussed. ALPIC 2012 will also highlight current knowledge in Antiplatelet and Anticoagulant therapy in patients with cardiovascular disease and will present recent advances in the development of new inhibitors of Platelet activation as well as new Anticoagulants.

An internationally recognized panel of invited speakers will present state-of-the-art lectures on the above scientific fields and will create an excellent opportunity to stimulate an extended and very constructive discussion both inside and outside the meeting room.

The magnificent location and the picturesque landscapes offered by Metsovo, will add to the scientific quality of the presentations, making this event a remarkable one for all participants. The Organizers will spare no efforts to ensure that ALPIC 2012 will be an exciting and enriching experience.

We look forward to welcoming you all in January 2012.

With our best regards,

Goudevenos John               Tselepis Alexandros
Professor of Cardiology       Professor of Biochemistry-Clinical Chemistry
Medical School                  Department of Chemistry
University of Ioannina          University of Ioannina

Donna Castellone

Bookmark and Share


About the Author

Donna Castellone,  MS, MT(ASCP)SH

Donna Castellone,

View Complete Profile


Previous Posts


RSS Feed

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.